Email updates

Keep up to date with the latest news and content from JTM and BioMed Central.

This article is part of the supplement: 7th European Workshop on Immune-Mediated Inflammatory Diseases

Open Access Open Badges Poster presentation

SOCS2 expression in bone marrow derived dendritic cells is a positive regulator of T cell activation

Jin Hu1*, Berit Carow4, Ann-Charlotte Wikström3, Martin Rottenberg4, Gunnar Norstedt2 and Ola Winqvist1

  • * Corresponding author: Jin Hu

Author Affiliations

1 Dept. of Medicine, Translational Immunology Unit, Karolinska Institutet, Stockholm, Sweden

2 Dept. of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

3 Dept. of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden

4 Dept. of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

For all author emails, please log on.

Journal of Translational Medicine 2012, 10(Suppl 3):P19  doi:10.1186/1479-5876-10-S3-P19

The electronic version of this article is the complete one and can be found online at:

Published:28 November 2012

© 2012 Hu et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


After a completed T cell response the activation of DCs needs to be terminated to avoid harmful inflammation or autoimmune disease. Besides the negative regulation of JAK/STAT signaling pathway on growth hormone and prolactin for suppressor of cytokine signaling (SOCS) 2 [1], murine SOCS2-/- DCs are recently found to be hyper-responsive to microbial stimuli and refractory to the inhibitory actions of the anti-inflammatory mediator LXA4 [2]. Thus, we investigate the role of SOCS2 in DC antigen presentation.

Materials and methods

Mice: SOCS2 deficient mice and transgenic OT-II mice. Mouse bone marrow-derived dendritic cells (BMDCs): Mouse bone marrow cells were incubated 7 days with 20 ng/ml GM-CSF and 20 ng/ml IL-4 to create mouse BMDCs. Quantitative RT-PCR: Real-time PCR was used to measure pro-inflamatory cytokines gene expression. CFSE proliferation assay: BMDCs were incubated with 100 ng/ml LPS and 50 ng/ml OVA323-339 peptide. The next day CD90+ splenocytes from OT-II mice were labeled with CFSE and added to the BMDC culture for 5 days. Then cells were stained for CD4 and read by FACS.


Increased production of pro-inflammatory cytokines by SOCS2-/- BMDCs in response to LPS (see Figure 1)

thumbnailFigure 1. The effect of SOCS2 KO, on pro-inflammatory cytokine release in LPS induced BMDCs. BMDCs from WT and SOCS2 mice were stimulated with LPS (100 ng/ml) till 48 hours. mRNA expression of indicated cytokines was measured at the indicated time points.

SOCS-/- BMDCs have a decreased capacity to activate naïve CD4+ T cells (see Figure 2)

thumbnailFigure 2. Proliferation of CD4+ T antigen specific cells is decreased when co-cultured with SOCS2-/- mice BMDCs The CFSE-labeled OTII CD4+ T cells were co- cultured with DCs alone, LPS matured DCs, or LPS matured DCs plus OVA from WT and SOCS2 mice, respectively. The CD4 Tcells were harvested to determine the number of divisions by flow cytometry after 5 days.


SOCS2 is complex regulator of DC effecter functionality, with an overall positive regulatory function on T cell activation.


  1. Rico-Bautista E, Flores-Morales A, Fernandez-Perez L: Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions.

    Cytokine Growth Factor Rev 2006, 17:431-439. PubMed Abstract | Publisher Full Text OpenURL

  2. Machado FS, Johndrow JE, Esper L, Dias A, Bafica A, et al.: Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent.

    Nat Med 2006, 12:330-334. PubMed Abstract | Publisher Full Text OpenURL